Rare lephants
Screener

Mineralys Therapeutics, Inc.

MLYS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jan 9, 2026
4 Jan 6, 2026 FORM 4
8-K Jan 6, 2026 8-K
144 Jan 2, 2026
4 Nov 24, 2025 FORM 4
4 Nov 21, 2025 FORM 4
144 Nov 20, 2025
4 Nov 13, 2025 FORM 4
4 Nov 13, 2025 FORM 4
4 Nov 13, 2025 FORM 4
4 Nov 13, 2025 FORM 4
144 Nov 13, 2025
144 Nov 13, 2025
144 Nov 12, 2025
144 Nov 12, 2025
S-3ASR Nov 10, 2025 S-3ASR
10-Q Nov 10, 2025 10-Q
8-K Nov 10, 2025 8-K
4 Oct 15, 2025 FORM 4
4 Oct 15, 2025 FORM 4
4 Oct 15, 2025 FORM 4
144 Oct 15, 2025
144 Oct 14, 2025
144 Oct 14, 2025
4 Sep 16, 2025 FORM 4
← Newer Page 6 of 17 · 406 filings Older →